Results 11 to 20 of about 94,351 (149)
Cancer Science, Volume 114, Issue 11, Page 4343-4354, November 2023., 2023 Gilteritinib demonstrated significantly improved antitumor efficacy tha alectinib against ALK‐rearranged NSCLC cells. Abstract Gilteritinib is a multitarget tyrosine kinase inhibitor (TKI), approved for the treatment of FLT3‐mutant acute myeloid leukemia, with a broad range of activity against several tyrosine kinases including anaplastic lymphoma ...
Chihiro Ando +20 more
wiley +1 more source
Nursing Open, Volume 9, Issue 3, Page 1612-1624, May 2022., 2022 Abstract Aim To develop self‐management support platform on mobile for Chinese patients with lung cancer. Design A stepwise approach with combination of methods. Methods Literature review was carried out to construct preliminary framework and develop detailed content for self‐management modules.
Xiaosha Ni +7 more
wiley +1 more source
Clinical features and outcomes of patients with stage I multiple primary lung cancers
Cancer Science, Volume 112, Issue 5, Page 1924-1935, May 2021., 2021 This study determined the clinical features and outcomes of synchronous and metachronous multiple primary lung cancer. This information could have major implications regarding diagnosis and identification of independent prognostic factors, and provide valuable information for postoperative management of patients with multiple primary lung cancer ...
Yasushi Shintani +16 more
wiley +1 more source
Cancer Medicine, Volume 10, Issue 3, Page 1043-1056, February 2021., 2021 No significant difference was seen in any anticancer treatments in solid tumor subgroup. Chemotherapy, however, will lead to a higher mortality in patients with hematological malignancies. Abstract Background The relationship between cancer and COVID‐19 has been revealed during the pandemic.
Hanqing Liu +6 more
wiley +1 more source
Chinese Medical Entity Recognition Model Based on Character and Word Vector Fusion
Scientific Programming, Volume 2021, Issue 1, 2021., 2021 The medical information carried in electronic medical records has high clinical research value, and medical named entity recognition is the key to extracting valuable information from large‐scale medical texts. At present, most of the studies on Chinese medical named entity recognition are based on character vector model or word vector model.
Qinghui Zhang +5 more
wiley +1 more source
Cancer Science, Volume 111, Issue 5, Page 1685-1691, May 2020., 2020 This study provides the benchmark statistics on medically treated patients with lung cancer in Japan. Here, 3‐year survival rates of patients treated with concurrent chemoradiotherapy (n = 1689), sequential chemoradiotherapy (n = 221), thoracic radiotherapy alone (n = 662), chemotherapy alone (n = 7790) and palliative care alone (n = 1952) were 43.6 ...
Ikuo Sekine +12 more
wiley +1 more source
, 1989 肺癌 = Japanese Journal of Lung Cancer, 29(5), p.587: 1989journal ...
木田, 晴海 +6 more
core +1 more source
山梨肺癌研究会の6年間の肺癌登録結果につき、以下の8点につき発表した。1.年間登録数。登録癌の、2.組織型、3.発生部位、4.臨床病期。5.医療機関への受診動機。6.外科療法と絶対治癒手術の比率。7.登録時死亡。8.その他。いずれも、6年間を通じて著しい変化を認めなかった。山梨県の肺癌死は年間30人ずつ増加しており、その原因究明と対策にも地域癌登録は必須であり ...
松川, 哲之助 +5 more
core +1 more source
転移性多発脳腫瘍と左上葉原発の肺癌を認め、精査の後、肺腺癌cT2aNOMlb(BRA)、stagelVと診断した。また、入院時の喀痰検査で塗抹2+、結核菌PCR陽性であったこと、CT画像で気道散布性の陰影を認めたことから、活動性肺結核も合併していると診断した。結核菌は死菌である可能性はあるものの、抗結核治療を開始し、併せて肺癌に対する定位放射線治療(stereotactic radiotherapy;SRT)、抗癌剤治療(CBDCA+PEM)を行った。神経症状は改善し、画像上腫瘍は縮小したため ...
内田, 賢典 +5 more
core +1 more source
肺癌の外科的療法 : 主題 肺癌 : 第28回九州支部会 [PDF]
, 1969 肺癌 = Japanese Journal of Lung Cancer, 9(3-4), p.79: 1969journal ...
富田, 正雄, 辻, 泰邦
core +1 more source